Company Filing History:
Years Active: 2006
Title: Volker Böttger: Innovator in Cancer Research
Introduction
Volker Böttger is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of cancer research, particularly through his innovative work on inhibitors that target the interaction between the P53 protein and MDM2 oncogene.
Latest Patents
Böttger holds a patent for "Inhibitors of the interaction between P53 and MDM2." This invention relates to compounds that can bind to the oncogene protein MDM2. The patent outlines processes for preparing these compounds, pharmaceutical preparations that include them, and their therapeutic uses, especially in treating human patients. The invention also details methods and compounds aimed at inhibiting the growth of tumor cells that contain the wild type p53 suppressor by disrupting the interaction between human p53 and human MDM2. He has 1 patent to his name.
Career Highlights
Böttger's career has been marked by his dedication to advancing cancer treatment methodologies. His work has been instrumental in developing new therapeutic strategies that target specific molecular interactions involved in tumor growth.
Collaborations
Throughout his career, Böttger has collaborated with notable figures in the field, including David Philip Lane and Angelika Böttger. These partnerships have enhanced the impact of his research and contributed to the advancement of cancer therapies.
Conclusion
Volker Böttger's innovative work in cancer research exemplifies the critical role of inventors in developing new therapeutic strategies. His contributions continue to influence the field and offer hope for improved cancer treatments.